drugset

drugset / Trial / NCT00868530

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

NCT00868530 ↗

Phase 3 Completed 53 enrolled Pfizer

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of on-demand treatment with Xyntha in Chinese hemophilia A subjects.

Timeline

Start: 2008-09
Primary completion: 2009-12
Completion: 2009-12

Publications

Yang R, Zhao Y, Wang X, Sun J, Wu R, Jin C, Jin J, Wu D, Rendo P, Sun F, Rupon J, Huard F, Korth-Bradley JM, Xu L, Luo B, Liu YC. Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies. J Blood Med. 2020 Nov 25;11:439-448. doi: 10.2147/JBM.S241605. eCollection 2020.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Moroctocog alfa	Protein / enzyme biologic	50 iu/kg	Intravenous

Indications